Singular Genomics Systems Inc (OMIC)
21.65
-0.25
(-1.14%)
USD |
NASDAQ |
Nov 22, 15:47
Singular Genomics Systems Total Liabilities (Quarterly): 63.30M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 63.30M |
| June 30, 2024 | 82.30M |
| March 31, 2024 | 82.40M |
| December 31, 2023 | 86.46M |
| September 30, 2023 | 85.49M |
| June 30, 2023 | 65.59M |
| March 31, 2023 | 65.14M |
| December 31, 2022 | 67.65M |
| Date | Value |
|---|---|
| September 30, 2022 | 68.55M |
| June 30, 2022 | 68.85M |
| March 31, 2022 | 24.63M |
| December 31, 2021 | 19.48M |
| September 30, 2021 | 18.76M |
| June 30, 2021 | 17.40M |
| March 31, 2021 | 228.96M |
| December 31, 2020 | 82.06M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
17.40M
Minimum
Jun 2021
228.96M
Maximum
Mar 2021
70.44M
Average
68.10M
Median
Total Liabilities (Quarterly) Benchmarks
| Bruker Corp | 4.270B |
| Azenta Inc | 331.07M |
| Harvard Bioscience Inc | 65.92M |
| Bionano Genomics Inc | 38.49M |
| Akoya Biosciences Inc | 116.34M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 186.55M |
| Shareholders Equity (Quarterly) | 123.25M |
| Debt to Equity Ratio | 0.0419 |
| Current Ratio | 7.372 |
| Net Debt Paydown Yield | 2.53% |